Cargando…

Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study

OBJECTIVE: The purpose of this research is to investigate the relationship between zonulin levels and diminished ovarian reserve (DOR), and to evaluate the potential role of autoimmunity in the development of DOR. The study contributes to the understanding of the pathogenesis of DOR, which can be an...

Descripción completa

Detalles Bibliográficos
Autores principales: Çelik, Sebahattin, Yurtcu, Nazan, Soyer Çalışkan, Canan, Çelik, Samettin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236232/
https://www.ncbi.nlm.nih.gov/pubmed/37260186
http://dx.doi.org/10.4274/tjod.galenos.2023.26037
_version_ 1785052871196147712
author Çelik, Sebahattin
Yurtcu, Nazan
Soyer Çalışkan, Canan
Çelik, Samettin
author_facet Çelik, Sebahattin
Yurtcu, Nazan
Soyer Çalışkan, Canan
Çelik, Samettin
author_sort Çelik, Sebahattin
collection PubMed
description OBJECTIVE: The purpose of this research is to investigate the relationship between zonulin levels and diminished ovarian reserve (DOR), and to evaluate the potential role of autoimmunity in the development of DOR. The study contributes to the understanding of the pathogenesis of DOR, which can be an unexpected diagnosis often associated with infertility and unpleasant physical symptoms in women. MATERIALS AND METHODS: This cross-sectional study was conducted by scanning 224 patients. The demographic characteristics of the patients were recorded. Antral follicle counts of the patients were determined by ultrasound, and Anti-Mullerian hormone (AMH) levels were examined. Follicle-stimulating hormone (FSH), luteinizing hormone, estradiol, AMH measurement, and antral follicle counts were made on the 2nd or 3rd day of menstrual bleeding. The zonulin levels of the participants were measured by the ELISA method. The patients were divided into two groups according to the presence of DOR. The patients’ demographic characteristics and hormone levels were compared between these two groups, serum zonulin levels were examined, and the relationship between other hormone parameters and zonulin was investigated. RESULTS: When the median ages of the patients in both groups were compared, the median age of patients with DOR was 38 years, significantly higher (p<0.001) than the median age of those without DOR, which was 27 years. The median zonulin levels of both groups were compare; it was observed that it was 19.71 ng/mL in the group with DOR and 11.03 ng/mL without DOR, and a statistically significant difference was found between the zonulin levels of the patients in both groups (p<0.001). A moderate inverse correlation (p<0.001) between patients’ zonulin and AMH levels, and a moderate correlation between FSH levels (p<0.001). CONCLUSION: In conclusion, zonulin levels of patients with DOR were higher than women without DOR. Evaluation of zonulin levels may also be considered during the diagnosis of DOR.
format Online
Article
Text
id pubmed-10236232
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-102362322023-06-03 Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study Çelik, Sebahattin Yurtcu, Nazan Soyer Çalışkan, Canan Çelik, Samettin Turk J Obstet Gynecol Clinical Investigation OBJECTIVE: The purpose of this research is to investigate the relationship between zonulin levels and diminished ovarian reserve (DOR), and to evaluate the potential role of autoimmunity in the development of DOR. The study contributes to the understanding of the pathogenesis of DOR, which can be an unexpected diagnosis often associated with infertility and unpleasant physical symptoms in women. MATERIALS AND METHODS: This cross-sectional study was conducted by scanning 224 patients. The demographic characteristics of the patients were recorded. Antral follicle counts of the patients were determined by ultrasound, and Anti-Mullerian hormone (AMH) levels were examined. Follicle-stimulating hormone (FSH), luteinizing hormone, estradiol, AMH measurement, and antral follicle counts were made on the 2nd or 3rd day of menstrual bleeding. The zonulin levels of the participants were measured by the ELISA method. The patients were divided into two groups according to the presence of DOR. The patients’ demographic characteristics and hormone levels were compared between these two groups, serum zonulin levels were examined, and the relationship between other hormone parameters and zonulin was investigated. RESULTS: When the median ages of the patients in both groups were compared, the median age of patients with DOR was 38 years, significantly higher (p<0.001) than the median age of those without DOR, which was 27 years. The median zonulin levels of both groups were compare; it was observed that it was 19.71 ng/mL in the group with DOR and 11.03 ng/mL without DOR, and a statistically significant difference was found between the zonulin levels of the patients in both groups (p<0.001). A moderate inverse correlation (p<0.001) between patients’ zonulin and AMH levels, and a moderate correlation between FSH levels (p<0.001). CONCLUSION: In conclusion, zonulin levels of patients with DOR were higher than women without DOR. Evaluation of zonulin levels may also be considered during the diagnosis of DOR. Galenos Publishing 2023-06 2023-06-01 /pmc/articles/PMC10236232/ /pubmed/37260186 http://dx.doi.org/10.4274/tjod.galenos.2023.26037 Text en ©Copyright 2023 by Turkish Society of Obstetrics and Gynecology | Turkish Journal of Obstetrics and Gynecology published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Investigation
Çelik, Sebahattin
Yurtcu, Nazan
Soyer Çalışkan, Canan
Çelik, Samettin
Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study
title Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study
title_full Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study
title_fullStr Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study
title_full_unstemmed Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study
title_short Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study
title_sort zonulin as a potential biomarker for diminished ovarian reserve: a prospective study
topic Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236232/
https://www.ncbi.nlm.nih.gov/pubmed/37260186
http://dx.doi.org/10.4274/tjod.galenos.2023.26037
work_keys_str_mv AT celiksebahattin zonulinasapotentialbiomarkerfordiminishedovarianreserveaprospectivestudy
AT yurtcunazan zonulinasapotentialbiomarkerfordiminishedovarianreserveaprospectivestudy
AT soyercalıskancanan zonulinasapotentialbiomarkerfordiminishedovarianreserveaprospectivestudy
AT celiksamettin zonulinasapotentialbiomarkerfordiminishedovarianreserveaprospectivestudy